In this interview we talk to Timothy Olah (Bristol-Myers Squibb) about his research and role as Group Director. He discusses his group’s responsibility for developing quantitative methods to measure novel therapeutics and biomarkers in discovery.
In this interview, Allena Ji (Sanofi Genzyme; MA, USA) discusses the advantages and challenges of using triple quadrupole mass spectrometry, the challenges associated with increasing biomarker assay sensitivity and how the field may be regulated and standardized.
In this interview with Ragu Ramanathan (Pfizer; NY, USA), Ragu describes his current research focuses in measuring and quantitating drugs and metabolites in animal and human samples. Ragu discusses the key challenges associated with studying drug/drug interactions (DDI), the benefits of current technologies available for studying DDI and what to expect from the upcoming Special Focus Issue from Bioanalysis on ‘Novel LC–MS assays impacting CYP and transporter DDI evaluation’.
In this interview, Natasha Savoie (Co-author and WRIB team member) discusses the publication of the decennial index of the White Papers in Bioanalysis.
In this interview, Robert Durham gives an overview of the new Gyrolab® xPand from Gyros Protein Technologies, presented at WRIB this year.
The 2018 Bioanalysis Rising Star Award finalists have been announced! Meet Jing Tu (PPD, VA, USA) your 2018 BRSA finalist.
The 2018 Bioanalysis Rising Star Award finalists have been announced! Meet Lisa O’Callaghan (Merck, PA, USA) your 2018 BRSA finalist.
The 2018 Bioanalysis Rising Star Award finalists have been announced! Meet Buyun Chen (Genentech, CA, USA) your 2018 BRSA finalist.
In this interview, Song Li from Frontage Laboratories (PA, USA) discusses the key challenges of outsourcing in the bioanalytical field, as well as his thoughts and perspectives on what the future holds for the relationship between CROs and pharma.
In this interview, Nico and Chad (PRA Health Sciences; NC, USA) discuss the advantages, disadvantages and challenges they face with the technologies they utilize, before predicting what the future holds for the field.